# The Medicines (Products for Human Use) (Fees) Regulations 2012, Paragraph 6: Marketing authorization: where Part 2 of the Act applies


In the case of an article or substance to which Part II of the Act applies by virtue of the Medicines (Surgical Materials) Order 1971, the fee payable under regulation 33(3) in connection with the holding of a marketing authorization or licence is £300.

---
Source: https://www.legislation.gov.uk/nisr/2012/134/schedule/4/paragraph/6 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2012/schedule-4/paragraph-6
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.